Theranostics — short for “therapy” and “diagnostics” — is an innovative cancer treatment that uses the same molecule to both detect and destroy cancer cells. This approach delivers a radioactive drug that binds to specific receptors on tumor cells, allowing your care team to first locate cancer through imaging and then deliver radiation directly to those same cells.
At Endeavor Health, we’re proud to offer FDA-approved theranostic therapies like Pluvicto® for metastatic prostate cancer and Lutethera for advanced neuroendocrine tumors — and we’re constantly expanding access as new therapies are developed for other cancer types.
Clinical trials
Endeavor Health participates in clinical trials exploring new applications of theranostics, including earlier use in prostate cancer, and treatment for other tumor types like neuroendocrine cancers.
Latest insights in cancer care
The Endeavor Health Cancer Institute delivers advanced therapies like theranostics through collaborative care, precision imaging and personalized support — offering you new hope through innovation.
